Cite
HARVARD Citation
Roon, J. et al. (n.d.). THU0238 CLINICAL EFFICACY OF LEFLUNOMIDE/HYDROXYCHLOROQUINE COMBINATION THERAPY IN PRIMARY SJOGREN'S SYNDROME IS PREDICTED BY SERUM PROTEOME BIOMARKERS – RESULTS FROM REPURPSS-I. Annals of the rheumatic diseases. p. 396. [Online].